XML 124 R95.htm IDEA: XBRL DOCUMENT v3.24.1
Other Non-Financial Assets - Additional Information (Details) - EUR (€)
€ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure Of Income And Expenses [Line Items]    
Deferred expenses € 313.2 € 120.0
OncoC4 Inc.    
Disclosure Of Income And Expenses [Line Items]    
Deferred expenses 22.5 0.0
Ryvu Therapeutics S.A.    
Disclosure Of Income And Expenses [Line Items]    
Deferred expenses 15.7 19.7
Medigene Immunotherapies GmbH    
Disclosure Of Income And Expenses [Line Items]    
Deferred expenses 5.1 9.4
European Commission To Collaboration Partner    
Disclosure Of Income And Expenses [Line Items]    
Deferred expenses € 151.1 € 0.0